QPPV.COM KNOWLEDGE ASSESSMENT

Somatropin Classification, Biology, Safety and Pharmacovigilance Knowledge Assessment

Test your understanding of the concepts covered by Somatropin: Classification, Growth Hormone Biology, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A growing child treated with somatropin develops a limp and hip pain. Which clinical possibility should receive particular attention?
Question 2 of 10 Why can thyroid monitoring be relevant after initiation of somatropin, particularly in a patient with pituitary disease?
Question 3 of 10 Which description best characterises somatropin for pharmacovigilance purposes?
Question 4 of 10 Why is adherence especially important when interpreting an apparent lack of somatropin efficacy?
Question 5 of 10 A patient develops hyperglycaemia after a somatropin dose increase. Which additional information would be most useful for case assessment?
Question 6 of 10 Which statement best expresses the central pharmacovigilance principle for somatropin?
Question 7 of 10 A medication history states only that a patient is receiving 'growth hormone'. What is the most important pharmacovigilance improvement?
Question 8 of 10 Which combination best reflects the metabolic actions relevant to somatropin safety monitoring?
Question 9 of 10 What is the most appropriate interpretation of oedema, arthralgia or paraesthesia in an adult receiving somatropin?
Question 10 of 10 A child receiving somatropin develops headache, nausea and blurred vision. Which follow-up is most appropriate for evaluating possible intracranial hypertension?

Select an answer to continue.

QPPV.com